BRIEF-Acorda Therapeutics Q4 GAAP loss per share $0.07
February 14, 2017 at 06:08 AM EST
* Acorda provides financial and pipeline update for fourth quarter and year end 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.